Early detection of cancer is one of the unmet needs in clinical medicine. Peripheral blood analysis is a preferred method for efficient population screening, because blood collection is well embedded in clinical practice and minimally invasive for patients. Lipids are important biomolecules, and variations in lipid concentrations can reflect pathological disorders. Lipidomic profiling of human plasma by the coupling of ultrahigh-performance supercritical fluid chromatography and mass spectrometry is investigated with the aim to distinguish patients with breast, kidney, and prostate cancers from healthy controls. The mean sensitivity, specificity, and accuracy of the lipid profiling approach were 85%, 95%, and 92% for kidney cancer; 91%, 97%, and 94% for breast cancer; and 87%, 95%, and 92% for prostate cancer. No association of statistical models with tumor stage is observed. The statistically most significant lipid species for the differentiation of cancer types studied are CE 16:0, Cer 42:1, LPC 18:2, PC 36:2, PC 36:3, SM 32:1, and SM 41:1 These seven lipids represent a potential biomarker panel for kidney, breast, and prostate cancer screening, but a further verification step in a prospective study has to be performed to verify clinical utility.

Comprehensive Cancer Center Nový Jičín Hospital Nový Jičín Nový Jičín Czech Republic

Department of Analytical Chemistry Faculty of Chemical Technology University of Pardubice Studentská 573 532 10 Pardubice Czech Republic

Department of Oncology Faculty of Medicine and Dentistry Palacký University and University Hospital 1 P Pavlova 6 775 20 Olomouc Czech Republic

Zobrazit více v PubMed

Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. PubMed DOI

National Cancer Institute. Cancer staging. Cancer.gov. https://www.cancer.gov/about-cancer/understanding/what-is-cancer. Updated 9 Feb 2021.

Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate cancer incidence and mortality rates. Eur. Urol. 2020;77:38–52. doi: 10.1016/j.eururo.2019.08.005. PubMed DOI

Ahmad, A. Breast Cancer Statistics: Recent Trends In Breast Cancer Metastasis and Drug Resistance: Challenges and Progress (ed. Ahmad, A.) 1–7 (Springer, 2019).

Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F. International variations and trends in renal cell carcinoma incidence and mortality. Eur. Urol. 2015;67:519–530. doi: 10.1016/j.eururo.2014.10.002. PubMed DOI

Li P, et al. Regional geographic variations in kidney cancer incidence rates in European countries. Eur. Urol. 2015;67:1134–1141. doi: 10.1016/j.eururo.2014.11.001. PubMed DOI

Descotes J-L. Diagnosis of prostate cancer. Asian J. Urol. 2019;6:129–136. doi: 10.1016/j.ajur.2018.11.007. PubMed DOI PMC

Jafari SH, et al. Breast cancer diagnosis: Imaging techniques and biochemical markers. J. Cell. Physiol. 2018;233:5200–5213. doi: 10.1002/jcp.26379. PubMed DOI

Capitanio U, Montorsi F. Renal cancer. Lancet. 2016;387:894–906. doi: 10.1016/S0140-6736(15)00046-X. PubMed DOI

Ljungberg B, et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur. Urol. 2010;58:398–406. doi: 10.1016/j.eururo.2010.06.032. PubMed DOI

Lennon AM, et al. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science. 2020;369:eabb9601. doi: 10.1126/science.abb9601. PubMed DOI PMC

Amin MB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J. Clin. 2017;67:93–99. doi: 10.3322/caac.21388. PubMed DOI

Tanos R, Thierry AR. Clinical relevance of liquid biopsy for cancer screening. Transl. Cancer Res. 2018;7:S105–S129. doi: 10.21037/tcr.2018.01.31. DOI

Chen M, Zhao HY. Next-generation sequencing in liquid biopsy: Cancer screening and early detection. Hum. Genomics. 2019;13:10. doi: 10.1186/s40246-019-0220-8. PubMed DOI PMC

Cohen JD, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018;359:926. doi: 10.1126/science.aar3247. PubMed DOI PMC

Zhang L, Han X, Wang X. Is the clinical lipidomics a potential goldmine? Cell Biol. Toxicol. 2018;34:421–423. doi: 10.1007/s10565-018-9441-1. PubMed DOI PMC

Kordalewska M, et al. Multiplatform metabolomics provides insight into the molecular basis of chronic kidney disease. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2019;1117:49–57. doi: 10.1016/j.jchromb.2019.04.003. PubMed DOI

Yang K, Han X. Lipidomics: Techniques, applications, and outcomes related to biomedical sciences. Trends Biochem. Sci. 2016;41:954–969. doi: 10.1016/j.tibs.2016.08.010. PubMed DOI PMC

Wolrab D, Jirásko R, Chocholoušková M, Peterka O, Holčapek M. Oncolipidomics: Mass spectrometric quantitation of lipids in cancer research. Trends Anal. Chem.: TrAC. 2019;120:115480. doi: 10.1016/j.trac.2019.04.012. DOI

Buszewska-Forajta M, et al. Lipidomics as a diagnostic tool for prostate cancer. Cancers. 2021 doi: 10.3390/cancers13092000. PubMed DOI PMC

Holčapek M, Liebisch G, Ekroos K. Lipidomic analysis. Anal. Chem. 2018;90:4249–4257. doi: 10.1021/acs.analchem.7b05395. PubMed DOI

Liebisch G, et al. Lipidomics needs more standarization. Nat. Metab. 2019;1:745–747. doi: 10.1038/s42255-019-0094-z. PubMed DOI

Wolrab, D. et al. Lipidomic profiling of human serum enables detection of pancreatic cancer Nat. Com., revision, preprint available at medRxiv: https://www.medrxiv.org/content/10.1101/2021.01.22.21249767v1 (2021). PubMed DOI PMC

Holčapek, M., Cífková, E., Lísa, M., Jirásko, R., Wolrab, D., Hrnčiarová, T. A Method of Diagnosing Pancreatic Cancer Based on Lipidomic Analysis of a Body Fluid. European patent EP3514545 (granted), date of filling 22.1.2018.

Holčapek, M., Wolrab, D., Jirásko, R., Cífková, E. A Method of Diagnosing Cancer Based on Lipidomic Analysis of a Body Fluid. EP18174963.1 (pending), filing date 29.5.2018.

Sales S, et al. Gender, contraceptives and individual metabolic predisposition shape a healthy plasma lipidome. Sci. Rep. 2016;6:27710. doi: 10.1038/srep27710. PubMed DOI PMC

West AL, et al. Lipidomic analysis of plasma from healthy men and women shows phospholipid class and molecular species differences between sexes. Lipids. 2021;56:229–242. doi: 10.1002/lipd.12293. PubMed DOI PMC

Chen X, et al. Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions. Oncotarget. 2016;7:36622–36631. doi: 10.18632/oncotarget.9124. PubMed DOI PMC

Cala MP, et al. Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women. PLoS ONE. 2018;13:e0190958. doi: 10.1371/journal.pone.0190958. PubMed DOI PMC

Cui M, Wang Q, Chen G. Serum metabolomics analysis reveals changes in signaling lipids in breast cancer patients. Biomed. Chromatogr. 2016;30:42–47. doi: 10.1002/bmc.3556. PubMed DOI

Guo Y, et al. Simultaneous Quantification of Serum Multi-Phospholipids as Potential Biomarkers for Differentiating Different Pathophysiological states of lung, stomach, intestine, and pancreas. J. Cancer. 2017;8:2191–2204. doi: 10.7150/jca.19128. PubMed DOI PMC

Lin L, et al. LC-MS-based serum metabolic profiling for genitourinary cancer classification and cancer type-specific biomarker discovery. Proteomics. 2012;12:2238–2246. doi: 10.1002/pmic.201200016. PubMed DOI

Yu Z, et al. Global lipidomics identified plasma lipids as novel biomarkers for early detection of lung cancer. Oncotarget. 2017;8:107899–107906. doi: 10.18632/oncotarget.22391. PubMed DOI PMC

Guo Y, et al. Probing gender-specific lipid metabolites and diagnostic biomarkers for lung cancer using Fourier transform ion cyclotron resonance mass spectrometry. Clin. Chim. Acta. 2012;414:135–141. doi: 10.1016/j.cca.2012.08.010. PubMed DOI

Zhou X, et al. Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics. PLoS ONE. 2012;7:e48889. doi: 10.1371/journal.pone.0048889. PubMed DOI PMC

Patel N, Vogel R, Chandra-Kuntal K, Glasgow W, Kelavkar U. A novel three serum phospholipid panel differentiates normal individuals from those with prostate cancer. PLoS ONE. 2014;9:e88841. doi: 10.1371/journal.pone.0088841. PubMed DOI PMC

Bielecka-Dbrowa A, Hannam S, Rysz J, Banach M. Malignancy-associated dyslipidemia. Open Cardiovasc. Med. J. 2011 doi: 10.2174/1874192401105010035. PubMed DOI PMC

Bergheanu SC, et al. Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: Investigating differential effects among statins. Curr. Med. Res. Opin. 2008;24:2477–2487. doi: 10.1185/03007990802321709. PubMed DOI

Tiwary S, Berzofsky JA, Terabe M. Altered lipid tumor environment and its potential effects on NKT cell function in tumor immunity. Front. Immun. 2019 doi: 10.3389/fimmu.2019.02187. PubMed DOI PMC

Gil-De-Gómez L, Balgoma D, Montero O. Lipidomic-based advances in diagnosis and modulation of immune response to cancer. Metabolites. 2020;10:1–15. doi: 10.3390/metabo10080332. PubMed DOI PMC

Guo R, et al. The function and mechanism of lipid molecules and their roles in the diagnosis and prognosis of breast cancer. Molecules. 2020 doi: 10.3390/molecules25204864. PubMed DOI PMC

Louie SM, Roberts LS, Mulvihill MM, Luo K, Nomura DK. Cancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipids. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 1831;1566–1572:2013. doi: 10.1016/j.bbalip.2013.07.008. PubMed DOI PMC

Cui M, Wang Q, Chen G. Serum metabolomics analysis reveals changes in signaling lipids in breast cancer patients. Biomed. Chromatogr. 2016;30:42–47. doi: 10.1002/bmc.3556. PubMed DOI

Sheridan M, Ogretmen B. The role of ceramide metabolism and signaling in the regulation of mitophagy and cancer therapy. Cancers. 2021 doi: 10.3390/cancers13102475. PubMed DOI PMC

Law SH, et al. An updated review of lysophosphatidylcholine metabolism in human diseases. Int. J. Mol. Sci. 2019 doi: 10.3390/ijms20051149. PubMed DOI PMC

Rolin J, Maghazachi AA. Effects of lysophospholipids on tumor microenvironment. Cancer Microenviron. 2011;4:393–403. doi: 10.1007/s12307-011-0088-1. PubMed DOI PMC

Ahn HS, et al. Convergence of plasma metabolomics and proteomics analysis to discover signatures of high-grade serous ovarian cancer. Cancers. 2020;12:1–20. doi: 10.3390/cancers12113447. PubMed DOI PMC

Liu J, et al. Serum metabolomic patterns in patients with autoimmune thyroid disease. Endocr. Pract. 2020;26:82–96. doi: 10.4158/EP-2019-0162. PubMed DOI

Kartsoli S, Kostara CE, Tsimihodimos V, Bairaktari ET, Christodoulou DK. Lipidomics in non-alcoholic fatty liver disease. World J. Hepatol. 2020;12:436–450. doi: 10.4254/wjh.v12.i8.436. PubMed DOI PMC

Marczak L, et al. Mass spectrometry-based lipidomics reveals differential changes in the accumulated lipid classes in chronic kidney disease. Metabolites. 2021 doi: 10.3390/metabo11050275. PubMed DOI PMC

Wolrab D, Chocholoušková M, Jirásko R, Peterka O, Holčapek M. Validation of lipidomic analysis of human plasma and serum by supercritical fluid chromatography–mass spectrometry and hydrophilic interaction liquid chromatography–mass spectrometry. Anal. Bioanal. Chem. 2020;412:2375–2388. doi: 10.1007/s00216-020-02473-3. PubMed DOI

Lísa M, Holčapek M. High-throughput and comprehensive lipidomic analysis using ultrahigh-performance supercritical fluid chromatography-mass spectrometry. Anal. Chem. 2015;87:7187–7195. doi: 10.1021/acs.analchem.5b01054. PubMed DOI

Wolrab D, Cífková E, et al. LipidQuant tool for automated data processing in lipid class separation-mass spectrometry workflows. Bioinformatics. 2021 doi: 10.1093/bioinformatics/btab644. PubMed DOI

Lísa M, Cífková E, Khalikova M, Ovčačíková M, Holčapek M. Lipidomic analysis of biological samples: Comparison of liquid chromatography, supercritical fluid chromatography and direct infusion mass spectrometry methods. J. Chromatogr. A. 2017;1525:96–108. doi: 10.1016/j.chroma.2017.10.022. PubMed DOI

Wang M, Wang Ch, Han X. Selection of internal standards for accurate quantification of complex lipid species in biological extracts by electrospray ionization mass spectrometry—What, how and why? Mass Spectrom. Rev. 2016;36:693–714. doi: 10.1002/mas.21492. PubMed DOI PMC

Eastment HT, Krzanowski WJ. Cross-validatory choice of the number of components from a principal component analysis. Technometrics. 1982;24:73–77. doi: 10.2307/1267581. DOI

Martens, H. & Naes, T. M. v. C., Wiley, Chichester (1989).

Yu G. Using ggtree to visualize data on tree-like structures. Curr. Protoc. Bioinform. 2020;69:e96. doi: 10.1002/cpbi.96. PubMed DOI

Four-Dimensional Lipidomic Analysis Using Comprehensive Online UHPLC × UHPSFC/Tandem Mass Spectrometry

Comprehensive characterization of complex glycosphingolipids in human pancreatic cancer tissues

Altered Plasma, Urine, and Tissue Profiles of Sulfatides and Sphingomyelins in Patients with Renal Cell Carcinoma